The HUDERF Pneumology-Allergology Clinic is dedicated to respiratory diseases and allergies, from screening to treatment. It also supports adolescents who want to stop smoking. Much of the clinic's activity is devoted to the neonatal screening, diagnosis and multidisciplinary care of patients with cystic fibrosis and the follow-up of patients with rare respiratory diseases.
"All the consulting rooms and treatment areas are decorated with frescoes so that the children will feel as comfortable as possible."
The clinic is specialised in diagnostic and interventional bronchoscopy and in treating the following diseases:
- Cystic fibrosis
- Primary ciliary dyskinesia
- Non-cystic fibrosis bronchiectasis
- Asthma and severe asthma
- Interstitial lung disease
- Pulmonary malformations
- Diaphragmatic hernia
- Esophageal atresia with fistula
- Bronchopulmonary dysplasia in premature babies.
The clinic also carries out:
- cutaneous tests
- functional respiratory tests including LCI measurement
- stress tests
- food reintroduction and drugs tests.
For cystic fibrosis and primary ciliary dyskinesia the clinic works in multidisciplinary teams that include doctors, a nurse, a physiotherapist, a dietitian, a psychologist, a social worker, a pharmacist and a secretary.
The Pneumology-Allergology Clinic works closely with other medical specialities, with the ULB neonatal screening service and with the pediatric research laboratory.
It has a number of specific units:
- An asthma and severe asthma unit
- A unit for food allergies, including anaphylaxis
- A drug allergy unit
- A cystic fibrosis reference centre that is a part of the European clinical trials network – ECFS-CTN
- A sports unit
The Clinic's expertise is recognised both nationally and internationally.
Our medical specialist
The patient is literally the centre of attention! On arrival, the cystic fibrosis or primary ciliary dyskinesia patient is accompanied to a consulting room where he or she is seen by a series of team members. This reduces the time spent at the hospital and the risk of cross infection! The clinic participates in many international studies and randomised quality studies
A Pilot Study of Lung Clearance Index as a Useful Outcome Marker in the Follow-Up of Pediatric Patients with Non-Cystic Fibrosis Bronchiectasis?
- Authors : Alkoussa W, Hanssens L, Sputael V, De Lucia F, Quentin C.
- Journal : Children 2023;10:791.
CFTR Protein: Not Just a Chloride Channel ?
- Authors : Hanssens LS, Duchateau J, Casimir GJ.
- Journal : Cells 2021 Oct 22;10(11):2844.
The Number of X Chromosomes Influences Inflammatory Cytokine Production Following Toll-Like Receptor Stimulation.
- Authors : Lefèvre N, Corazza F, Valsamis J, Delbaere A, De Maertelaer V, Duchateau J, Casimir GJ.
- Journal : Front Immunol 2019 May 9;10:1052.
The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study.
- Authors : Hanssens L, Thiébaut I, Lefèvre N, Malfroot A, Knoop C, Duchateau J, Casimir G.
- Journal : Prostaglandins Leukot Essent Fatty Acids 2016 May;108:45-50.